Clinical Trial Update: SBRT With Atezo/Bev for HCC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of SBRT (stereotactic body radiotherapy) with atezolizumab and bevacizumab for hepatocellular carcinoma; enrol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING